Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study
Year: 2025
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Previous studies have indicated that progression independent of relapse activity (PIRA) is uncommon in patients with aquaporin- 4 antibody-positive (AQP4-IgG) neuromyelitis optica spectrum disorder (NMOSD). However, the patterns of disability accumulation in seronegative NMOSD are unknown. This study aimed to evaluate the prevalence of PIRA and relapse-associated worsening (RAW) in seronegative NMOSD. METHODS: We conducted a retrospective, multicentre cohort study of seronegative NMOSD patients from the MSBase registry. Inclusion criteria required at least three recorded expanded disability status scale (EDSS) scores: baseline, progression, and 6 months confirmed disability progression (CDP). For those with 6-month CDP, the presence or absence of relapse between baseline and progression determined the classification as RAW or PIRA, respectively. Descriptive statistics were employed to present the data. RESULTS: This study included 93 patients, with a median follow-up duration of 5.0 years (Q1 2.8, Q3 8.4). The cohort predominantly consisted of female patients (77.4%), with a median age of onset of 33.9 years (Q1 26.1, Q3 41.2). PIRA was observed in 1 case (1.1%), whilst RAW was documented in 7 cases (7.5%). CONCLUSION: This international cohort study confirms that CDP is uncommon in seronegative NMOSD. Given more than three quarters of CDP occur due to RAW, therapeutic strategies should focus primarily on preventing relapses.
Source: Journal of Neurology
Authors: Pakeeran Siriratnam, Saif Huda, Anneke Van der Walt, Paul Sanfilippo, Sifat Sharmin, Yi Chao Foong, Wei Zhen Yeh, Chao Zhu, Samia J. Khoury, Tunde Csepany, Barbara Willekens, Masoud Etemadifar, Serkan Ozakbas, Petra Nytrova, Ayse Altintas, Abdullah Al-Asmi, Cristina Ramo-Tello, Guy Laureys, Francesco Patti, Dana Horakova, Matteo Foschi, Cavit Boz, Pamela McCombe, Recai Turkoglu, Izanne Roos, Jeannette Lechner-Scott, Tomas Kalincik, Vilija Jokubaitis, Helmut Butzkueven, Mastura Monif
Institutions: The Alfred Hospital, Walton Centre, Alfred Health, Monash University, The Royal Melbourne Hospital, The University of Melbourne, Royal Hobart Hospital, American University of Beirut Medical Center, University of Debrecen, University of Antwerp, Antwerp University Hospital, Isfahan University of Medical Sciences, İzmir University of Economics, Charles University, General University Hospital in Prague, Koç University, Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi, Sultan Qaboos University Hospital, Hospital Universitari Germans Trias i Pujol, Ghent University Hospital, University of Catania, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco", Karadeniz Technical University, University of L'Aquila, The University of Queensland, Haydarpaşa Numune Eğitim ve Araştırma Hastanesi, John Hunter Hospital, Hunter Medical Research Institute, Hunter New England Local Health District, University of Newcastle Australia, Monash Health
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,790
Funder: Monash University
OpenAlex ID: W4409430952
